Duquesne Family Office’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-659,750	Closed	-$3.77M	–	74
2023 Q4	$3.77M	Hold	659,750	–	–	0.12%	47
2023 Q3	$3.04M	Hold	659,750	–	–	0.11%	37
2023 Q2	$4.26M	Hold	659,750	–	–	0.15%	47
2023 Q1	$4.97M	Hold	659,750	–	–	0.22%	40
2022 Q4	$6.68M	Hold	659,750	–	–	0.33%	39
2022 Q3	$6.53M	Hold	659,750	–	–	0.37%	44
2022 Q2	$7.03M	Hold	659,750	–	–	0.51%	26
2022 Q1	$6.43M	Hold	659,750	–	–	0.29%	36
2021 Q4	$9.43M	Hold	659,750	–	–	0.34%	30
2021 Q3	$13.2M	Buy	+659,750	New	+$11.7M	0.43%	34
2021 Q2	–	Sell	-659,750	Closed	-$22.4M	–	54
2021 Q1	$22.4M	Hold	659,750	–	–	0.5%	43
2020 Q4	$26.5M	Buy	+659,750	New	+$30.2M	0.72%	33